Write what you believe about your stocks; every morning the cited record grades it: supported, challenged, or untouched. Never opinions.

Development · 1 Nov 2026

AJANTPHARM, full dossier

Ajanta Pharma का मुनाफा 49% बढ़कर 388 करोड़ रुपए रहा.

3 publishers have reported this development. Each act of reporting is below, cited.

The record

Ajanta Pharma का मुनाफा 49% बढ़कर 388 करोड़ रुपए रहा.

zeebiz.com30 Oct 2026

Net profit of Ajanta Pharma rose 49.18% to Rs 388.14 crore in the quarter ended September 2026 as against Rs 260.19 crore during the previous quarter ended September 2025.

Ajanta Pharma's net profit rose 49% to ₹388 crore in Q2 FY27, compared with ₹260.2 crore in the corresponding quarter last year.

cnbctv18.com30 Oct 2026

Ajanta Pharmaceuticals

₹3,360.60

▲ +2.33%

Close (EOD), as of 16 Nov 2026 · source

Ajanta Pharmaceuticals: results, dividends, orders, the full cited record →

Every claim carries its citation

This page is the corroborated record of one development: what each credible source reported, linked and dated. We compile and cite; we do not opine.

New here? The reader's guide explains every page, plate by plate.

fregime is informational research software. Content on this page is factual reporting compiled from cited public sources; nothing here is advice, and nothing here expresses an opinion on any security. fregime is not registered with SEBI as an investment adviser or research analyst. Before making investment decisions, consult a SEBI-registered adviser. Price figures are delayed end-of-day values cited to the exchange's published file, never live quotes.